By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) — A test commonly used to confirm a condition ...

Save 5% on FC24 coins using my code "MattHD" at <a href=" I Opened 35 x Icon/Campaign Year in Review Player picks in EA FC 24 ...

Robinhood (HOOD) topped tempered analyst estimates in the first quarter of 2025, reporting adjusted earnings per share of ...

(RTTNews) - Ascletis Pharma Inc. (ASCLF.PK) announced positive topline results from its randomized, double-blind, placebo-controlled Phase Ib multiple ascending dose (MAD) study of ASC30 oral once ...

Gilead Sciences said that it saw positive results from the phase 3 study of its Trodelvy therapy in combination with Merck's Keytruda in patients with inoperable locally advanced or metastatic ...

(AZN.L, AZN), Plus Pertuzumab showed positive topline results in a phase 3 trial in breast cancer patients. The results from a planned interim analysis of the DESTINY-Breast09 phase 3 trial showed ...

"[There is] nothing positive from today except from Charles finishing on the podium which was great for the team." Lewis Hamilton's fifth-place finish in Bahrain is his best result of the season ...

That's a bad bet, Posen warned. In his view, there's a 5% to 10% chance the US could achieve 1% GDP growth, that would only result from an "irresponsible fiscal stimulus" package, going beyond ...

Thursday’s results are the first from several studies of the daily pill, called orforglipron, expected this year from Lilly in patients with Type 2 diabetes and obesity. If the pill is approved ...

Orforglipron, Eli Lilly’s investigational oral glucagon-like peptide 1 receptor agonist (GLP-1 RA), achieved positive phase 3 results for both A1c and weight loss, according to top-line data ...

Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over ...

Investing.com -- Shares of Eli Lilly and Company (NYSE:LLY) surged over 14% Thursday following the announcement of positive Phase 3 trial results for orforglipron, a pioneering oral medication for ...